Case-Control Study of Rotavirus Vaccine Effectiveness Compared to Test-Negative Controls or Hospital Controls

被引:8
|
作者
Araki, Kaoru [1 ,2 ]
Hara, Megumi [1 ]
Shimanoe, Chisato [1 ]
Nishida, Yuichiro [1 ]
Matsuo, Muneaki [2 ]
Tanaka, Keitaro [1 ]
机构
[1] Saga Univ, Fac Med, Dept Prevent Med, 5-1-1 Nabeshima, Saga 8498501, Japan
[2] Saga Univ, Dept Pediat, Fac Med, Saga, Japan
关键词
hospital controls; rotavirus; vaccine effectiveness; test-negative controls; INFLUENZA VACCINE; SUSTAINED EFFECTIVENESS; EFFICACY; SAFETY; METAANALYSIS; DESIGN; JAPAN;
D O I
10.2188/jea.JE20180054
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Selection of test-negative controls takes less time and costs less than traditional control selection for evaluating vaccine effectiveness (VE). Here, rotavirus VE was evaluated using hospital controls and compared with test-negative controls to determine whether using the latter can substitute for the former. Methods: We recorded gastroenteritis in children from 2 months to 2 years of age at six medical facilities in Saga City between January 4th and May 31st, 2014. Stools from all identified acute gastroenteritis patients were tested for rotavirus using immunochromatography. Rotavirus gastroenteritis (RVGE) cases had test-positive stool, whereas test-negative controls had gastroenteritis but no rotavirus infection; hospital controls were outpatients visiting the same facility for indications other than gastroenteritis. Vaccination status was verified by inspecting maternal and child health records, and demographic data were obtained from a questionnaire completed by the patients' guardians or from the medical records. Unconditional logistic regression analysis was used to adjust for possible confounding factors. Results: Sixty-four RVGE cases, 260 test-negative controls, and 589 hospital controls were enrolled. The characteristics of the two control groups, including RV vaccination history, were similar. The RVGE cases were more likely to have used daycare services than children from either of the two control groups. The VE against RVGE estimated using hospital controls was 86.6% (95% confidence interval [CI], 55.9-96.0%), very similar to the VE using test-negative controls (84.9% [95% CI, 49.6-95.5%]). Conclusions: The estimated VE using test-negative controls and hospital controls is similar. Therefore, test-negative controls are considered appropriate for establishing VE.
引用
收藏
页码:282 / 287
页数:6
相关论文
共 50 条
  • [1] Use of Patients With Diarrhea Who Test Negative for Rotavirus as Controls to Estimate Rotavirus Vaccine Effectiveness Through Case-Control Studies
    Tate, Jacqueline E.
    Patel, Manish M.
    Cortese, Margaret M.
    Payne, Daniel C.
    Lopman, Benjamin A.
    Yen, Catherine
    Parashar, Umesh D.
    CLINICAL INFECTIOUS DISEASES, 2016, 62 : S106 - S114
  • [2] A comparison of the test-negative and traditional case-control study designs with respect to the bias of estimates of rotavirus vaccine effectiveness
    Haber, Michael
    Lopman, Benjamin A.
    Tate, Jacqueline E.
    Shi, Meng
    Parashar, Umesh D.
    VACCINE, 2018, 36 (33) : 5071 - 5076
  • [3] EVALUATION OF THE TEST-NEGATIVE CASE-CONTROL DESIGN TO ESTIMATE ROTAVIRUS VACCINE EFFECTIVENESS IN LOW-INCOME SETTINGS
    Schwartz, Lauren M.
    Halloran, M. Elizabeth
    Rowhani-Rahbar, Ali
    Neuzil, Kathleen M.
    Victor, J. Chris
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 377 - 378
  • [4] Effectiveness and impact of monovalent rotavirus vaccination in Afghanistan: a test-negative case-control analysis
    Anwari, Palwasha
    Burnett, Eleanor
    Safi, Najibullah
    Samsor, Akmal
    Safi, Helah
    Chavers, Tyler P.
    Parashar, Umesh D.
    Clark, Andrew D.
    Tate, Jacqueline E.
    LANCET GLOBAL HEALTH, 2024, 12 (09): : e1517 - e1525
  • [5] Correction of vaccine effectiveness derived from test-negative case-control studies
    Habibzadeh, Farrokh
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [6] Vaccine effectiveness against COVID-19 related hospital admission in the Netherlands: A test-negative case-control study
    Niessen, F. A.
    Knol, M. J.
    Hahne, S. J. M.
    Bonten, M. J. M.
    Bruijning-Verhagen, P. C. J. L.
    VACCINE, 2022, 40 (34) : 5044 - 5049
  • [7] The Use of Test-negative Controls to Monitor Vaccine Effectiveness A Systematic Review of Methodology
    Chua, Huiying
    Feng, Shuo
    Lewnard, Joseph A.
    Sullivan, Sheena G.
    Blyth, Christopher C.
    Lipsitch, Marc
    Cowling, Benjamin J.
    EPIDEMIOLOGY, 2020, 31 (01) : 43 - 64
  • [8] Effectiveness of Covishield vaccine in preventing Covid-19-A test-negative case-control study
    Pramod, Stuti
    Govindan, Dhanajayan
    Ramasubramani, Premkumar
    Kar, Sitanshu Sekhar
    Aggarwal, Rakesh
    VACCINE, 2022, 40 (24) : 3294 - 3297
  • [9] A Retrospective Test-Negative Case-Control Study to Evaluate Influenza Vaccine Effectiveness in Preventing Hospitalizations in Children
    Yildirim, Inci
    Kao, Carol M.
    Tippett, Ashley
    Suntarattiwong, Piyarat
    Munye, Mohamed
    Yi, Jumi
    Elmontser, Mohnd
    Quincer, Elizabeth
    Focht, Chris
    Watson, Nora
    Bilen, Hande
    Baker, Julia M.
    Lopman, Ben
    Hogenesch, Elena
    Rostad, Christina A.
    Anderson, Evan J.
    CLINICAL INFECTIOUS DISEASES, 2021, 73 (10) : 1759 - 1767
  • [10] Feasibility of case-control and test-negative designs to evaluate dengue vaccine effectiveness in Malaysia
    Nealon, Joshua
    Lim, Wei-Yin
    Moureau, Annick
    Lojikip, Sharon Linus
    Junus, Suria
    Kumar, Suresh
    Nachiappan, Jeyaseelan P.
    Sekaran, Shamala Devi
    Radigue, Cedric
    Cowling, Benjamin J.
    Ochiai, R. Leon
    Amar-Singh, H. S. S.
    VACCINE, 2019, 37 (39) : 5891 - 5898